Alexis Johnston

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Benign Prostatic Hyperplasia

Radical Prostatectomy

Histone Deacetylase

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Silvia Caggia, Alexis Johnston, Dipak T Walunj, Aanya R Moore, Benjamin H Peer, Ravyn W Everett, Adegboyega K Oyelere, Shafiq A Khan
Gα i 2 Protein Inhibition Blocks Chemotherapy- and Anti-Androgen-Induced Prostate Cancer Cell Migration. Cancers 16 (2) (2024)
Silvia Caggia, Alexis Johnston, Dipak T Walunj, Aanya R Moore, Benjamin H Peer, Ravyn W Everett, Adegboyega K Oyelere, Shafiq A Khan
Gα i 2 Protein Inhibition Blocks Chemotherapy- and Anti-Androgen-Induced Prostate Cancer Cell Migration. Cancers 16 (2) (2024)
Silvia Caggia, Alexis Johnston, Dipak T Walunj, Aanya R Moore, Benjamin H Peer, Ravyn W Everett, Adegboyega K Oyelere, Shafiq A Khan
Gα i 2 Protein Inhibition Blocks Chemotherapy- and Anti-Androgen-Induced Prostate Cancer Cell Migration. Cancers 16 (2) (2024)
Balaji Chandrasekaran, Subhasish Tapadar, Bocheng Wu, Uttara Saran, Ashish Tyagi, Alexis Johnston, David A Gaul, Adegboyega K Oyelere, Chendil Damodaran
Antiandrogen-Equipped Histone Deacetylase Inhibitors Selectively Inhibit Androgen Receptor (AR) and AR-Splice Variant (AR-SV) in Castration-Resistant Prostate Cancer (CRPC). Cancers 15 (6) (2023)
Balaji Chandrasekaran, Subhasish Tapadar, Bocheng Wu, Uttara Saran, Ashish Tyagi, Alexis Johnston, David A Gaul, Adegboyega K Oyelere, Chendil Damodaran
Antiandrogen-Equipped Histone Deacetylase Inhibitors Selectively Inhibit Androgen Receptor (AR) and AR-Splice Variant (AR-SV) in Castration-Resistant Prostate Cancer (CRPC). Cancers 15 (6) (2023)